These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9822045)
21. Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol. Campelo M; Polónia J; Serrão P; Cerqueira-Gomes M Cardiology; 1996; 87(5):402-8. PubMed ID: 8894261 [TBL] [Abstract][Full Text] [Related]
22. Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension--preliminary results. Madej A; Gierek-Ciaciura S; Haberka M; Lekston-Madej J; Basiak M; Domańska O; Okopień B Ups J Med Sci; 2010 Nov; 115(4):249-52. PubMed ID: 20858158 [TBL] [Abstract][Full Text] [Related]
23. Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension. Tuncer M; Gunes Y; Guntekin U; Gumrukcuoglu HA; Eryonucu B Adv Ther; 2008 Feb; 25(2):99-105. PubMed ID: 18297254 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of moxonidine in mild to moderate hypertension. Jain S; Malhotra P; Kumari S; Varma S J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474 [TBL] [Abstract][Full Text] [Related]
26. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy]. Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070 [TBL] [Abstract][Full Text] [Related]
27. The effect of rapid local cooling on human finger nailfold capillary blood pressure and blood cell velocity. Hahn M; Shore AC J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):109-14. PubMed ID: 7965826 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring. Martina B; Weinbacher M; Gasser P; Rhyner K; Köhler M; Wohler D; LeBloch Y; Bart T J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S89-92. PubMed ID: 7700075 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension. Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R; Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270 [TBL] [Abstract][Full Text] [Related]
30. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension]. Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890 [TBL] [Abstract][Full Text] [Related]
31. Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Masajtis-Zagajewska A; Majer J; Nowicki M Hypertens Res; 2010 Apr; 33(4):348-53. PubMed ID: 20139920 [TBL] [Abstract][Full Text] [Related]
32. [The Israeli trial with cilazapril (Vasocase) for the treatment of hypertension--summary of the care of 413 patients in a community health setting]. Zimlichman R Harefuah; 2000 Mar; 138(5):345-50, 424. PubMed ID: 10883128 [TBL] [Abstract][Full Text] [Related]
33. Comparison of moxonidine and clonidine HCl in treating patients with hypertension. Plänitz V J Clin Pharmacol; 1987 Jan; 27(1):46-51. PubMed ID: 3316304 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension. Chrysant SG; Marbury TC; Robinson TD J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of cilazapril in patients with essential hypertension. Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074 [TBL] [Abstract][Full Text] [Related]
36. The acute effects of cilazapril on pulmonary function tests and arterial blood gas changes in patients with pulmonary hypertension. Tavli T; Sekuri C; Goktalay T; Uyanik BS; Ari Z Int J Clin Pharmacol Res; 2003; 23(2-3):53-9. PubMed ID: 15018019 [TBL] [Abstract][Full Text] [Related]
37. [The effect of cilazapril on left ventricular function and myocardial perfusion in patients with essential hypertension (hypertensive disease) stage II]. Karpov RS; Pavliukova EN; Kapishchenko TD; Chernov VI Ter Arkh; 1995; 67(9):50-3. PubMed ID: 7495043 [TBL] [Abstract][Full Text] [Related]
38. The short-term effects of cilazapril on left ventricular diastolic function. Koylan N; Oncül A; Mercanoğlu F; Orak E; Erzengin F; Büyüköztürk K J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S42-4. PubMed ID: 7700064 [TBL] [Abstract][Full Text] [Related]
39. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril. Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364 [TBL] [Abstract][Full Text] [Related]
40. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Chazova I; Almazov VA; Shlyakhto E Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]